OTCMKTS:ATTBF Abattis Bioceuticals (ATTBF) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free ATTBF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2,500 shsAverage Volume11,650 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartStock AnalysisChart Get Abattis Bioceuticals alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About Abattis Bioceuticals Stock (OTCMKTS:ATTBF)Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. ATTBF Stock News HeadlinesNovember 11, 2023 | morningstar.comAbattis Bioceuticals Corp ATTBFSeptember 9, 2022 | morningstar.comAbattis Bioceuticals Corp ATTBF SustainabilityApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 27, 2022 | benzinga.comWhen Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay?March 26, 2022 | benzinga.comCannabis Payments Co Launches Women In Finance & Technology ScholarshipMarch 25, 2022 | benzinga.comCharlotte's Web Q4 Revenue Up 5% QoQ, Adjusted EBITDA Loss Improves By $5MMarch 20, 2022 | benzinga.comFederal Marijuana Cases Drop Again In 2021 As More States LegalizeMarch 20, 2022 | benzinga.comSchwazze Common Shares Will Trade On NEO Exchange Under Symbol 'SHWZ' In Late MarchApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 9, 2022 | benzinga.comMDXclusive Launches Lab-Tested Topical And Sublingual CBD ProductsMarch 6, 2022 | benzinga.comThe Perfect CBD To THC Ratio? New Study Says 1 To 1 Is The Best Ratio For Therapeutic EffectsMarch 5, 2022 | benzinga.comMost D.C. Workers To Avoid Pre-Employment Marijuana Testing Under New BillMarch 3, 2022 | benzinga.comBDSA Report: Global Cannabis Sales Will Jump 22% In 2022, Grow To $61B By 2026January 26, 2022 | benzinga.comTrulieve Files Resale Registration With SEC For Subordinate Voting Shares Of 2021 AcquisitionsDecember 22, 2021 | benzinga.comLatest Issue Of Psychedelics Mag DoubleBlind Plays With The Tension Between Old And NewOctober 18, 2021 | benzinga.comMicah Tapman Of BDSA Lays Out Cannabis Data In The NortheastSeptember 3, 2021 | benzinga.comApple's Cannabis iPhone App Is Benefiting Businesses And Consumers, Where's Google Play Store?August 31, 2021 | benzinga.comPanama Is Close To Legalizing Medicinal CannabisAugust 18, 2021 | benzinga.comEXCLUSIVE: Healthcare Attorney Brian Rath Discusses Medical Marijuana In Nursing Homes & Assisted Living, Legal? It's ComplicatedSee More Headlines Receive ATTBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abattis Bioceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:ATTBF CUSIPN/A CIKN/A Webwww.abattis.com Phone808-650-3007FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Robert J. Abenante BBA (Age 41)CA, MPAcc, President, CEO & Director Comp: $276.74kMr. Francesco PaoliniCFO & DirectorMr. Patrick MitchellCOO & DirectorMr. Shawn BalaghiHead of Corporate DevelopmentMr. Jim CarterHead of Mergers and Acquisitions AdvisoryMr. Christopher P. Cherry C.A. (Age 45)CPA, CA, CGA, CPA, Corporate Comptroller Ms. Nicole BreitingerCorporate SecretaryMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors ATTBF Stock Analysis - Frequently Asked Questions How do I buy shares of Abattis Bioceuticals? Shares of ATTBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ATTBF) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abattis Bioceuticals Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
